Drugs could mimic gut bacteria benefits to treat diabetesIt may be possible to design drugs that mimic the positive health benefits of gut bacteria to treat Share XDrugs could mimic gut bacteria benefits to treat diabeteshttps://pharmaphorum.com/news/drugs-gut-bacteria-diabetes/
Alnylam to file gene-silencing porphyria drugAlnylam is to file its givosiran with regulators to treat a form of the blood disease porphyria, applying Share XAlnylam to file gene-silencing porphyria drughttps://pharmaphorum.com/news/alnylam-to-file-gene-silencing-porphyria-drug/
J&J’s Invokana reduces risk of renal failure in high-risk diabetes patientsJohnson & Johnson’s Janssen pharma unit has announced new results showing that its Invokana diabetes medicine is the Share XJ&J’s Invokana reduces risk of renal failure in high-risk diabetes patientshttps://pharmaphorum.com/news/jjs-invokana-reduces-risk-of-renal-failure-in-high-risk-diabetes-patients/
Strength in numbers: Because having a rare disease isn’t rareRare doesn’t mean insignificant – in fact more people live with a rare disease than with cancer and Share XStrength in numbers: Because having a rare disease isn’t rarehttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/global-genes-rare-diseases/
R&D Roundup: Pharma gets in on the biotech boomSome good news for the UK industry in turbulent times is always welcome, and several announcement this month Share XR&D Roundup: Pharma gets in on the biotech boomhttps://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-pharma-gets-in-on-the-biotech-boom/
The patient perspective on advocacyGrowing up with the shadow of Huntington’s disease (HD) means Seth Rotberg understands the importance of peer support Share XThe patient perspective on advocacyhttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/inspire-patient-advocacy-seth-rotberg/
Navigating new frontiers: Ways to find space in the future RA marketOverview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
Understanding blockchain – a practical guide for life sciences companiesWithin the life science industry, uptake of blockchain is in the early stages, but with investment levels in Share XUnderstanding blockchain – a practical guide for life sciences companieshttps://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/
Marketing science – brand innovation for pharmaCombining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as Share XMarketing science – brand innovation for pharmahttps://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/
Containment Solutions and ADC Developments to be discussed at HPAPI Conference 2019SMi is delighted to present its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference, taking place in London Share XContainment Solutions and ADC Developments to be discussed at HPAPI Conference 2019https://pharmaphorum.com/partner-content/containment-solutions-and-adc-developments-to-be-discussed-at-hpapi-conference-2019/
Predictions for 2019: Ten trends that will shape the future of drug development and commercializationeBook Provides Biopharma Decision Makers With What’s Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead Share XPredictions for 2019: Ten trends that will shape the future of drug development and commercializationhttps://pharmaphorum.com/partner-content/press-releases/predictions-for-2019-ten-trends-that-will-shape-the-future-of-drug-development-and-commercialisation/
